癌症
医学
免疫系统
放射治疗
癌症研究
癌症治疗
癌细胞
生物信息学
机制(生物学)
更安全的
程序性细胞死亡
死因
癌症治疗
心脏功能不全
心脏毒性
药理学
心血管健康
肿瘤微环境
毒性
抗氧化剂
双重角色
神经科学
生物
心肌细胞
GPX4
免疫疗法
氧化应激
评论文章
旁观者效应
细胞凋亡
细胞存活
免疫学
脂质代谢
免疫原性细胞死亡
疾病
作者
Jiani Dai,Yufei Wang,ChunNa Jin,Liuguang Song,Yao Xie,Liangliang Jia,Meixiang Xiang
出处
期刊:Cells
[Multidisciplinary Digital Publishing Institute]
日期:2026-08-22
卷期号:15 (17): 1507-1507
标识
DOI:10.3390/cells15171507
摘要
Advances in anticancer therapies have substantially improved cancer survival but have also highlighted the growing challenge of cancer therapy-related cardiac dysfunction. Ferroptosis, an iron-dependent form of regulated cell death characterized by iron dysregulation, lipid peroxidation, and impaired antioxidant defense, has emerged as a promising strategy for eliminating therapy-resistant tumors. However, the lack of tissue specificity in ferroptosis regulation raises concerns regarding its potential contribution to cardiovascular injury during anticancer treatment. This review summarizes the dual roles of ferroptosis in cancer biology and cardio-oncology. We first discuss the molecular mechanisms governing ferroptosis, including iron metabolism, lipid peroxidation, and antioxidant defense systems. We then highlight the context-dependent roles of ferroptosis in tumor progression, immune regulation, and metabolic adaptation. Furthermore, we systematically review how chemotherapy, targeted therapy, immunotherapy, and radiotherapy contribute to ferroptosis-associated cardiovascular toxicity. Finally, we discuss emerging approaches to minimize cardiac injury, including tissue-specific ferroptosis-targeting and cardioprotective strategies. Understanding tissue-specific ferroptosis regulation may facilitate the development of safer and more precise therapeutic approaches in cardio-oncology.
科研通智能强力驱动
Strongly Powered by AbleSci AI